Most cited papers from Georg Speyer Haus

Georg Speyer Haus

What are the most cited papers from Georg Speyer Haus?

The most cited paper from Georg Speyer Haus is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "A framework for advancing our understanding of cancer-associated fibroblasts" (3,962) and "Inflammation and Cancer: Triggers, Mechanisms, and Consequences" (3,881).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 232 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors	23 Nov 2018	11,535
2	A framework for advancing our understanding of cancer-associated fibroblasts Erik A. Sahai et al. · Nature reviews. Cancer ReviewOpen access	24 Jan 2020	3,962
3	Inflammation and Cancer: Triggers, Mechanisms, and Consequences Florian R. Greten, Sergei I. Grivennikov · Immunity Open access	Jul 2019	3,881
4	Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells Martin Göttlicher, Saverio Minucci, Ping Zhu et al. · The EMBO Journal Open access	17 Dec 2001	1,903
5	The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells Tony Gutschner, Monika Hämmerle, Moritz F. Eissmann et al. · Cancer Research Open access	15 Dec 2012	1,597
6	Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma Nabil M. Ahmed et al. · Journal of Clinical Oncology Open access	23 Mar 2015	1,001
7	Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel Growth Katharina Michalik, Xintian A. You, Yosif Manavski et al. · Circulation Research	7 Mar 2014	961
8	HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma Nabil M. Ahmed et al. · JAMA Oncology Open access	20 Apr 2017	854
9	Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during Embryogenesis Nicholas W. Gale, Sacha J. Holland, David M. Valenzuela et al. · Neuron Open access	Jul 1996	851
10	The inflammatory pathogenesis of colorectal cancer Mark R. Schmitt, Florian R. Greten · Nature reviews. Immunology Review	28 Apr 2021	807
11	Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease STEFAN P. STEIN et al. · Nature Medicine	24 Jan 2010	787
12	IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis Matjaž Rokavec, Meryem Gülfem Öner, Huihui Li et al. · Journal of Clinical Investigation Open access	18 Mar 2014	779
13	Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes Eric Delwart, Eugene G. Shpaer, Joost Louwagie et al. · Science	19 Nov 1993	776
14	Optimization of the preparation process for human serum albumin (HSA) nanoparticles Klaus Langer, Sabine Balthasar, Vitali Vogel et al. · International Journal of Pharmaceutics	25 Apr 2003	766
15	Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape Meenakshi G. Hegde et al. · Journal of Clinical Investigation Open access	17 Jul 2016	682
16	Visualization of a short-range Wnt gradient in the intestinal stem-cell niche Henner F. Farin, Ingrid Jordens, Mohammed H. Mosa et al. · Nature	Feb 2016	556
17	The role of Bcl-2 family members in tumorigenesis Vladimir Kirkin, Stefan Joos, Martin Zörnig · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Open access	6 Dec 2003	546
18	The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 Oliver Holger Krämer, Ping Zhu, Heather P. Ostendorff et al. · The EMBO Journal Open access	Jul 2003	530
19	High-Level Transduction and Gene Expression in Hematopoietic Repopulating Cells Using a Human Imunodeficiency Virus Type 1-Based Lentiviral Vector Containing an Internal Spleen Focus Forming Virus Promoter Christophe Demaison, Kathryn L. Parsley, Gaby S. Brouns et al. · Human Gene Therapy	May 2002	495
20	Bone marrow niches in haematological malignancies Simón Méndez‐Ferrer, Dominique A. Bonnet, David P. Steensma et al. · Nature reviews. Cancer ReviewOpen access	28 Feb 2020	488
21	Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles Jörg Kreuter, Peter Ramge, Valery E. Petrov et al. · Pharmaceutical Research	Mar 2003	471
22	TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy Zakaria Grada, Meenakshi G. Hegde, Tiara T. Byrd et al. · Molecular Therapy — Nucleic Acids Open access	2013	466
23	High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity Manon Dominique Schulz, Çiğdem Atay, Jessica Heringer et al. · Nature Open access	31 Aug 2014	460
24	Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth Florian Matthias Corvinus, Carina med. Orth, Richard Moriggl et al. · Neoplasia Open access	Jun 2005	437
25	Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis Joris Hemelaar et al. · The Lancet Infectious Diseases ReviewOpen access182 authors	30 Nov 2018	425
26	The CD95 Receptor: Apoptosis Revisited Marcus E. Peter, Ralph C. Budd, Julie Desbarats et al. · Cell Open access	May 2007	398
27	Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development Moritz F. Eissmann, Tony Gutschner, Monika Hämmerle et al. · RNA Biology Open access	Aug 2012	397
28	ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma Congcong Zhang, Michael C. Burger, Lukas Jennewein et al. · JNCI Journal of the National Cancer Institute	6 Dec 2015	394
29	Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma Tatyana Vagner, Cristiana Spinelli, Valentina R. Minciacchi et al. · Journal of Extracellular Vesicles Open access	7 Aug 2018	392
30	Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis Özge Canli, Adele M. Nicolas, J. R. P. Gupta et al. · Cancer Cell Open access	Dec 2017	360
31	3D model for CAR‐mediated cytotoxicity using patient‐derived colorectal cancer organoids Theresa Schnalzger, Marnix HP de Groot, Congcong Zhang et al. · The EMBO Journal Open access	29 Apr 2019	355
32	Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor Kurt Schönfeld et al. · Molecular Therapy Open access	6 Nov 2014	352
33	Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer Adele M. Nicolas et al. · Cancer Cell Open access	Feb 2022	351
34	The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer Arafath Kaja Najumudeen et al. · Nature Genetics	2021	339
35	STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis Christina Heichler et al. · Gut	4 Nov 2019	339
36	Reactive Oxygen Species Regulate Hematopoietic Stem Cell Self-Renewal, Migration and Development, As Well As Their Bone Marrow Microenvironment Aya Ludin, Shiri Gur‐Cohen, Karin Golan et al. · Antioxidants and Redox Signaling Open access	24 Apr 2014	339
37	NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy Garnet Suck, Marcus Odendahl, Paulina Nowakowska et al. · Cancer Immunology Immunotherapy Open access	11 Nov 2015	333
38	Fructose stimulated de novo lipogenesis is promoted by inflammation Jelena Todoric et al. · Nature Metabolism Open access	24 Aug 2020	327
39	Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer Georg Wolf, Robert Elez, A Doermer et al. · Oncogene	6 Feb 1997	327
40	Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition Bernd Groner, Viktoria von Manstein · Molecular and Cellular Endocrinology	31 May 2017	321
41	Activating natural cytotoxicity receptors of natural killer cells in cancer and infection Joachim Koch, Alexander Steinle, Carsten Watzl et al. · Trends in Immunology Review	13 Feb 2013	316
42	Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity Congcong Zhang, Pranav Oberoi, Sarah Oelsner et al. · Frontiers in Immunology Open access	18 May 2017	311
43	Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in China Ling Su, Marcus Graf, Yuanzhi Zhang et al. · Journal of Virology Open access	Dec 2000	299
44	Complexome Profiling Identifies TMEM126B as a Component of the Mitochondrial Complex I Assembly Complex Heinrich Heide, Lea Bleier, Mirco Steger et al. · Cell Metabolism Open access	13 Sep 2012	293
45	Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche Hayley L. Belnoue-Davis et al. · Nature Medicine Open access	24 Nov 2014	293
46	Induction and down-regulation of PLK, a humanserine/threonine kinase expressed in proliferating cells andtumors. Uwe Holtrich, Georg Wolf, Andreas Bräuninger et al. · Proceedings of the National Academy of Sciences Open access	Mar 1994	285
47	A guideline on the molecular ecosystem regulating ferroptosis Enyong Dai et al. · Nature Cell Biology Open access	29 Feb 2024	282
48	Inflammation: the incubator of the tumor microenvironment Dominic Denk, Florian R. Greten · Trends in cancer Review	27 Jul 2022	280
49	Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity Kilian B. Kennel, Müge Bozlar, Adalbert F. De Valk et al. · Clinical Cancer Research Open access	18 Nov 2022	278
50	Gene therapy on the move Kerstin B. Kaufmann, Hildegard Büning, Anne Galy et al. · EMBO Molecular Medicine Open access	17 Sep 2013	276

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.